107 related articles for article (PubMed ID: 28339283)
1. Development, optimization and implementation of a centralized metabolic soft spot assay.
Paiva AA; Klakouski C; Li S; Johnson BM; Shu YZ; Josephs J; Zvyaga T; Zamora I; Shou WZ
Bioanalysis; 2017 Apr; 9(7):541-552. PubMed ID: 28339283
[TBL] [Abstract][Full Text] [Related]
2. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
Trunzer M; Faller B; Zimmerlin A
J Med Chem; 2009 Jan; 52(2):329-35. PubMed ID: 19108654
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Metabolic Soft-Spot Identification in Liver Microsomes by LC/UV/MS: Application of a Single Variable Incubation Time Approach.
Zhu Y; Chen G; Zhang K; Chen C; Chen W; Zhu M; Jiang H
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432161
[TBL] [Abstract][Full Text] [Related]
4. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery.
Zelesky V; Schneider R; Janiszewski J; Zamora I; Ferguson J; Troutman M
Bioanalysis; 2013 May; 5(10):1165-79. PubMed ID: 23721441
[TBL] [Abstract][Full Text] [Related]
5. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.
Cece-Esencan EN; Fontaine F; Plasencia G; Teppner M; Brink A; Pähler A; Zamora I
Rapid Commun Mass Spectrom; 2016 Jan; 30(2):301-10. PubMed ID: 26689160
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in software tools for high-throughput in vitro ADME support with high-resolution MS.
Paiva A; Shou WZ
Bioanalysis; 2016 Aug; 8(16):1723-33. PubMed ID: 27487387
[TBL] [Abstract][Full Text] [Related]
7. A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening.
Zhang J; Vath M; Ferraro C; Li Y; Murphy K; Zvyaga T; Weller H; Shou W
Rapid Commun Mass Spectrom; 2013 Apr; 27(7):731-7. PubMed ID: 23495019
[TBL] [Abstract][Full Text] [Related]
8. High-throughput quantitative and qualitative analysis of microsomal incubations by cocktail analysis with an ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometer system.
Backfisch G; Reder-Hilz B; Hoeckels-Messemer J; Angstenberger J; Sydor J; Laplanche L; Schulz M
Bioanalysis; 2015; 7(6):671-83. PubMed ID: 25517264
[TBL] [Abstract][Full Text] [Related]
9. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
Xu R; Manuel M; Cramlett J; Kassel DB
J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
[TBL] [Abstract][Full Text] [Related]
10. Metabolic stability screen for drug discovery using cassette analysis and column switching.
Halladay JS; Wong S; Jaffer SM; Sinhababu AK; Khojasteh-Bakht SC
Drug Metab Lett; 2007 Jan; 1(1):67-72. PubMed ID: 19356021
[TBL] [Abstract][Full Text] [Related]
11. An Integrated Hepatocyte Stability Assay for Simultaneous Metabolic Stability Assessment and Metabolite Profiling.
Leung C; Liu J; Cunico K; Johnson K; Yan Z; Cai J
Drug Metab Dispos; 2024 Apr; 52(5):377-389. PubMed ID: 38438166
[TBL] [Abstract][Full Text] [Related]
12. [Metabolite profiling of two anti-HIV lead compounds in rat liver microsomes].
Wang R; Chen J; Qin BJ; Xie JW; Li H; Xie L
Yao Xue Xue Bao; 2012 Dec; 47(12):1671-7. PubMed ID: 23460975
[TBL] [Abstract][Full Text] [Related]
13. A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds.
Grubb MF; Humphreys WG; Josephs JL
Bioanalysis; 2012 Jul; 4(14):1747-61. PubMed ID: 22877221
[TBL] [Abstract][Full Text] [Related]
14. Strategy of using microsome-based metabolite production to facilitate the identification of endogenous metabolites by liquid chromatography mass spectrometry.
Clements M; Li L
Anal Chim Acta; 2011 Jan; 685(1):36-44. PubMed ID: 21168549
[TBL] [Abstract][Full Text] [Related]
15. High-throughput microsomal stability assay for screening new chemical entities in drug discovery.
Fonsi M; Orsale MV; Monteagudo E
J Biomol Screen; 2008 Oct; 13(9):862-9. PubMed ID: 18812573
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes.
Höppner S; Delahaut P; Schänzer W; Thevis M
J Pharm Biomed Anal; 2014 Jan; 88():649-59. PubMed ID: 24239904
[TBL] [Abstract][Full Text] [Related]
17. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
[TBL] [Abstract][Full Text] [Related]
18. Software-aided structural elucidation in drug discovery.
Ahlqvist M; Leandersson C; Hayes MA; Zamora I; Thompson RA
Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2083-9. PubMed ID: 26443410
[TBL] [Abstract][Full Text] [Related]
19. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion.
McNaney CA; Drexler DM; Hnatyshyn SY; Zvyaga TA; Knipe JO; Belcastro JV; Sanders M
Assay Drug Dev Technol; 2008 Feb; 6(1):121-9. PubMed ID: 18336089
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
